NCT02433457View on ClinicalTrials.gov

Relative Bioavailability Study of CC-292

PHASE1CompletedINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

May 26, 2014

Primary Completion Date

September 26, 2014

Study Completion Date

September 26, 2014

Conditions

Healthy Volunteers

Interventions

DRUG

CC-292

DRUG

Oral Omeprazole (OMP)

Trial Locations (1)

47710

Covance Clinical Research unit, Evansville

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Celgene

INDUSTRY